BCL2 and ovarian cancer: HAGLROS is an upregulated lncRNA in ovarian cancer cells; HAGLROS knockdown increases apoptosis rate, upregulates BAX protein expression, and downregulates BCL-2 protein expression via the HAGLROS/miR-26b-5p axis (Zhu and Mei, 2021[159]).